Gerburg M Wulf, MD
Professor
Medical Oncology
Contact Information
| Office: | DA-0517C |
| Phone: | 617-667-4765 |
| Fax: | |
| Email: | gwulf@bidmc.harvard.edu |
| Address: | 330 Brookline Ave; DA-0517C
Boston, MA 02215 |
Advanced Degree And Training
| Year | Institution | Area or Rank |
| 1989 | Westfaelische Wilhelms University | MD(1987) PhD (1989) |
| 1989 | University Heidelberg | resident in Medicine |
| 1991 | Harvard University/BIDMC | research fellow in hemato |
| 1994 | Tufts/St Elizabeth | resident in Medicine |
| 1996 | Harvard/BIDMC | fellow in Hematology/Onco |
| 1998 | Harvard/BIDMC | research fellow in Oncolo |
| 1999 | Harvard/BIDMC | Instructor in Medicine |
Research Lab Team Members
| Aaron Grant PhD |
Areas of Interest
| 1 Cancer |
Major Research Theme
| In my research, I am studying signal transduction, specifically the role of aberrant prolyl isomerization in breast cancer. Prolyl isomerization catalyzed by Pin1 is a post-phosphorylational regulatory mechanism that has recently been found to be important for signal transduction downstream from oncogenic Ras and Her2/Neu. Based on my basic laboratory work I have developed a strong interest in translational research, and I am working on a phase I study exploring the combination of Herceptin and Rad001 in metastatic Her2 breast cancer. |
Publications
External Recognition
| 1991 - 1993 Mildred-Scheel Cancer Research Foundation (Germany) PI: Gerburg M Wulf; Title: Role of the vav protooncogene in hematopoiesis 1999 - 2002 Department of Defense DAMD17-99-1-9081 PI: Gerburg M Wulf; Title: Roles of the Mitotic Checkpoint Regulators Pin1 and Pin2 in Breast Cancer 2002 - 2007 NIH K08 CA 93655-01A1 PI: Gerburg M Wulf; Title: Role of the Prolyl Isomerase Pin1 in Breast Cancer 2004 –2005 DFHCC Breast SPORE career Development Award PI: Gerburg M. Wulf 2005-2006 Department of Defense Concept Award; Mapping Primary Mammary Epithelial Cell Transformation PI: Gerburg M. Wulf 2005 Avon Supplement to P50 DFHCC/SPORE PI: Gerburg M. Wulf Treament of Metastatic Breast Cancer with Herceptin and a Rapamycin ester |
Major Collaborative Activities
| I am part of the Dana Farber Harvard Cancer Center and member of the Breast Cancer SPORE group |
Investigator's Lab Web Site
| Research Lab URL | None listed |
| Harvard Catalyst Site: | Wulf Harvard Catalyst Web Site |
